Your browser doesn't support javascript.
loading
Risk of bleeding in patients undergoing percutaneous endoscopic gastrotrostomy (PEG) tube insertion under antiplatelet therapy: a systematic review with a meta-analysis / Riesgo de sangrado en pacientes sometidos a inserción de un tubo de gastrostomía percutánea endoscópica y en tratamiento antiplaquetario: una revisión sistemática con metaanálisis
Lucendo, Alfredo J; Sánchez-Casanueva, Tomás; Redondo, Olga; Tenias, José M; Arias, Ángel.
Afiliação
  • Lucendo, Alfredo J; Hospital General de Tomelloso. Departments of Gastroenterology. Tomelloso. España
  • Sánchez-Casanueva, Tomás; Hospital General de Tomelloso. Departments of Hospital Pharmacy. Tomelloso. España
  • Redondo, Olga; Complejo Hospitalario La Mancha Centro. Research Unit. Alcázar de San Juan. España
  • Tenias, José M; Escola Valenciana d’ Studis de la Salut. Unitat Docent de Medicina Familiar i Comunitària. Valencia. España
  • Arias, Ángel; Complejo Hospitalario La Mancha Centro. Research Unit. Alcázar de San Juan. España
Rev. esp. enferm. dig ; 107(3): 128-136, mar. 2015. ilus, tab, graf
Artigo em Inglês | IBECS | ID: ibc-133836
Biblioteca responsável: ES1.1
Localização: BNCS
ABSTRACT
BACKGROUND AND

AIM:

Patients undergoing percutaneous endoscopic gastrostomy (PEG) tube placement often are under antiplatelet therapy with a potential thromboembolic risk if these medications are discontinued. This systematic review aims to assess if maintaining aspirin and/or clopidogrel treatment increases the risk of bleeding following PEG placement.

METHODS:

A systematic search of the MEDLINE, EMBASE, and SCOPUS databases was developed for studies investigating the risk of bleeding in patients on antiplatelet therapy undergoing PEG tube insertion. Summary estimates, including 95 % confidence intervals (CI), were calculated. A fixed or random effects model was used depending on heterogeneity (I2). Publication bias risks were assessed by means of funnel plot analysis.

RESULTS:

Eleven studies with a total of 6,233 patients (among whom 3,665 were undergoing antiplatelet treatment), met the inclusion criteria and were included in the quantitative summary. Any PEG tube placement-related bleeding was found in 2.67 % (95 % CI 1.66 %, 3.91 %) of the entire population and in 2.7 % (95 % CI 1.5 %, 4.1 %) of patients not receiving antiplatelet therapy. Pooled relative risk (RR) for bleeding in patients under aspirin, when compared to controls, was 1.43 (95 % CI 0.89, 2.29; I 2 = 0 %); pooled RR for clopidogrel was 1.21 (95 % CI 0.48, 3.04; I 2 = 0 %) and for dual antiplatelet therapy, 2.13; (95 % CI 0.77, 5.91; I2 = 47 %). No significant publication bias was evident for the different medications analyzed.

CONCLUSION:

Antiplatelet therapy was safe among patients undergoing PEG tube insertion. Future prospective and randomized studies with larger sample sizes are required to confirm the results of this study
RESUMEN
No disponible
Assuntos
Texto completo: Disponível Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Inibidores da Agregação Plaquetária / Gastrostomia / Hemorragia Pós-Operatória Tipo de estudo: Ensaio clínico controlado / Estudo de etiologia / Estudo prognóstico / Fatores de risco / Revisão sistemática Limite: Humanos Idioma: Inglês Revista: Rev. esp. enferm. dig Ano de publicação: 2015 Tipo de documento: Artigo Instituição/País de afiliação: Complejo Hospitalario La Mancha Centro/España / Escola Valenciana d’ Studis de la Salut/España / Hospital General de Tomelloso/España
Texto completo: Disponível Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Inibidores da Agregação Plaquetária / Gastrostomia / Hemorragia Pós-Operatória Tipo de estudo: Ensaio clínico controlado / Estudo de etiologia / Estudo prognóstico / Fatores de risco / Revisão sistemática Limite: Humanos Idioma: Inglês Revista: Rev. esp. enferm. dig Ano de publicação: 2015 Tipo de documento: Artigo Instituição/País de afiliação: Complejo Hospitalario La Mancha Centro/España / Escola Valenciana d’ Studis de la Salut/España / Hospital General de Tomelloso/España
...